LVW Advisors »

Outlook Therapeutics shares owned by LVW Advisors

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by LVW Advisors from 13F filings

Historical chart of LVW Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by LVW Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by LVW Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $255k 48k 5.34
2024-06-30 $352k 48k 7.38

More positions owned by LVW Advisors

Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Hdg Msci Eafe (HEFA)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Vanguard Bd Index Fds Intermed Term (BIV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Microsoft Corporation (MSFT)
Capital Group International SHS (CGIE)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Total Usd (IUSB)

View all positions for LVW Advisors

Top funds holding Outlook Therapeutics

Dr. Jeffrey R. Jay, M.D.
Tang Capital Management
BlackRock
Sphera Funds Management
Vanguard Group
Altium Capital Management
Caligan Partners
Schonfeld Strategic Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
LVW Advisors
Nuveen Asset Management
Susquehanna Fundamental Investments
Charles Schwab Investment Management

View all funds holding Outlook Therapeutics